Journal of Indian Society of Periodontology

CASE REPORT
Year
: 2014  |  Volume : 18  |  Issue : 6  |  Page : 781--785

Recombinant human bone morphogenetic protein type 2 in the reconstruction of atrophic maxilla: Case report with long-term follow-up


Andre Luiz Zetola1, Thalyta Verbicaro2, Sahara Littieri3, Rafaela Larson3, Allan Fernando Giovanini2, Tatiana Miranda Deliberador3, Andre Luiz Zetola1, Thalyta Verbicaro2, Sahara Littieri3, Rafaela Larson3, Allan Fernando Giovanini2, Tatiana Miranda Deliberador3 
1 Oral and Maxillofacial Surgeon, Chairman of Implantology, SOEPAR, Curitiba, PR, Brazil
2 Professor of Positivo University, Curitiba, PR, Brazil
3 Private Pratice, Curitiba, PR, Brazil

Correspondence Address:
Tatiana Miranda Deliberador
Prof. Pedro Viriato Parigot de Souza St, 5300 - CEP 81280 330 - Campo Comprido - Curitiba, PR
Brazil
Tatiana Miranda Deliberador
Prof. Pedro Viriato Parigot de Souza St, 5300 - CEP 81280 330 - Campo Comprido - Curitiba, PR
Brazil

Autologous bone is reported by scientific literature as the gold standard for the replacement of the bone loss in maxillary atrophic area. Notwithstanding, this grafting type shows several disadvantages as: The procedure morbidity, limited size of the graft and longer recovering time. Recombinant human bone morphogenetic protein type 2 (rhBMP-2) has been used as bone substitute for the reconstruction of large bone defects. The aim of this case was to report a clinical case exhibiting the reconstruction of the atrophic maxilla through using rhBMP-2 as grafting material associated with absorbable collagen sponge (ACS). At 8 months of following-up, osseointegrated implants were placed. After 2 years and 5 months of following-up, it could be observed an appropriate aesthetical and functional rehabilitation.


How to cite this article:
Zetola AL, Verbicaro T, Littieri S, Larson R, Giovanini AF, Deliberador TM, Zetola AL, Verbicaro T, Littieri S, Larson R, Giovanini AF, Deliberador TM. Recombinant human bone morphogenetic protein type 2 in the reconstruction of atrophic maxilla: Case report with long-term follow-up.J Indian Soc Periodontol 2014;18:781-785


How to cite this URL:
Zetola AL, Verbicaro T, Littieri S, Larson R, Giovanini AF, Deliberador TM, Zetola AL, Verbicaro T, Littieri S, Larson R, Giovanini AF, Deliberador TM. Recombinant human bone morphogenetic protein type 2 in the reconstruction of atrophic maxilla: Case report with long-term follow-up. J Indian Soc Periodontol [serial online] 2014 [cited 2020 Jul 16 ];18:781-785
Available from: http://www.jisponline.com/article.asp?issn=0972-124X;year=2014;volume=18;issue=6;spage=781;epage=785;aulast=Zetola;type=0